Findings from the BRIGHT trial published in JAMA

(Cardiovascular Research Foundation) Data from the BRIGHT trial published today in the Journal of the American Medical Association demonstrated that bivalirudin was superior to both heparin monotherapy and heparin plus tirofiban for patients with acute myocardial infarction undergoing percutaneous coronary intervention. Findings were first reported at last year's Transcatheter Cardiovascular Therapeutics, the annual scientific symposium of the Cardiovascular Research Foundation.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news